Stem cells or their exosomes: which is preferred in COVID-19 treatment?

Biotechnology Letters - It only took 8 months for the pneumonia caused by a previously unknown coronavirus to turn into a global pandemic of unprecedentedly far-reaching implications. Failure of...     

Mucormycosis: The hidden and forgotten disease

Mucormycosis is a rare but serious fungal infection caused by a group of moulds called mucormycetes. More attention has recently been paid to it due to its association with coronavirus disease 2019 (COVID-19). Thus, it is important to review the progress of studies on mucormycosis and highlight the important findings in relation to epidemiology, clinical manifestation, major risk factors, diagnostic strategies and management. An electronic literature search was performed in PubMed using the keywords: Rhizopus, Mucorales, mucormycosis, zygomycosis, zygomycetes, COVID-19, the drugs (azoles, posaconazole, isavuconazole, amphotericin B pharmaceutical preparations and caspofungin), combination therapy, diagnosis and clinical manifestations. Studies written in the English language from January 1960 to 2021 were considered for this review article. All search results were reviewed, and the relevance of each article was determined by the authors independently. The review emphasized the fact that the diagnosis of mucormycosis is difficult, it is necessary to have a high index of suspicion to identify it, surgical debridement should be done prior to the dissemination of infection to improve clinical outcomes and identifying underlying risk factors is important for proper treatment. Moreover, antifungal therapeutic options are few with polyenes and their combinations should be appropriate for empirical therapy while posaconazole and isavuconazole are best reserved for de-escalation, refractory cases or patients intolerant to amphotericin B.     

Approved spectrofluorimetric strategies for assurance of three modern antineoplastic drugs: tepotinib,sotorasib, and darolutamide in their dose forms and biological liquids utilizing mercurochrome

An approved, straightforward, fast, and delicate spectrofluorimetric strategy was developed for the estimation of tepotinib (TEPO), sotorasib (SOTO), and darolutamide (DARO) as new antineoplastic drugs. The spectrofluorimetric strategy was based on quantitative fluorescence quenching of MER at 538 nm after being excited at 350 nm by the addition of the cited drugs in the presence of acetate buffer (pH 3.5). The degree of fluorescence quenching was directly proportional to the concentrations of the cited drugs within the concentration range of 0.5–10.0, 0.2–10, and 0.4–10.0 μg ml⁻¹ for TEPO, SOTO, and DARO, respectively. Mean ± standard deviation (SD) were calculated for the studied drugs as follows; 99.9 ± 0.87, 99.72 ± 1.08, and 100.21 ± 1.44, for TEPO, SOTO, and DARO, respectively. Limit of detection (LOD) values were 0.16, 0.05, and 0.11 μg ml⁻¹, whereas limit of quantitation (LOQ) values were 0.5, 0.15, and 0.36 μg ml⁻¹ for TEPO, SOTO, and DARO, respectively. Statistical comparison through detailed strategies produced greater understanding and found that there were no noteworthy contrasts in exactness and exactness between strategies. The proposed strategy was used effectively to analyze the measurement of different forms of the examined drugs. Moreover, the recommended fluorimetric strategy was used for examination of TEPO, SOTO, and DARO in human plasma and urine tests.     

All-Optical Tunable Plasmonic Biosensor Made of Graphene and Metamaterial

Plasmonics - We demonstrate a novel, label-free and real-time tunable infrared biosensor by employing surface-plasmon polaritons in asymmetric Mach–Zehnder interferometer. The waveguides...     

Determination of rarefaction effects on transport properties of nanoscale gas flows using Green–Kubo molecular dynamic simulation

This study aimed to investigate the rarefaction effects on thermal conductivity, viscosity, and density of Argon, Neon and Xenon gas flows in a Platinum nanochannel. Green–Kubo approach with Lenard Jones potential function are used for molecular dynamic simulation. Simulations showed that with decrease in number of atoms, density, viscosity and thermal conductivity decreases, while decrease in nanochannel width in same number of gas atoms leads to increase in viscosity and thermal conductivity.     

Targeted-nanoliposomal combretastatin A4 (CA-4) as an efficient antivascular candidate in the metastatic cancer treatment

A number of antiangiogenic drugs have been approved by the Food and Drug Administration which are used in cancer therapy, and variety of other agents in several stages of clinical development or in preclinical assessment. Among these, combretastatin A4 (CA-4) is an under-researched inhibitor of angiogenesis that shows potential activity in the treatment of advanced tumors with migration capacity. However, its clinical application has been limited due to poor water solubility, low bioavailability, rapid metabolism, and systemic elimination. During the last decade, numerous investigations have been done to overcome these problems by using different CA-4 delivery systems or developing produgs of CA-4 or its structural analogs. Nevertheless, these strategies could not be efficient out of the undesired side effects on normal tissues. Nanoliposomal CA-4 not only benefits from the advantage of using liposomal drugs as opposed to free drugs but also can accumulate in the tumor site via specific targeting ligands, which leads to efficient targeting and enhancement of bioavailability. To the best of our knowledge, we consider an important attempt to understand different factors that might influence the CA-4 loading and release pattern of liposomes and the consequent results in tumor therapy. In this review, we shed light on various studied liposomal CA-4 formulations showing application thereof in cancer treatment.     

Effect of season on hormonal profile and some biochemical parameters at different stages of estrous cycles in Baladi goats

Understanding the seasonal patterns of estrus cycle in caprine is crucial to develop the efficient breeding plans in the subtropics. Thus, the aim of the current research was to evaluate the effects of breeding season on hormonal profile and blood biochemical indices at different stages of estrus cycle in normal breeding or out-of-season breeding in goats. Forty-four Baladi goats were monitored for a period of eight months (July–February). Baladi goats exhibit a normal seasonal breeding (NS) at midsummer and continue through the autumn season (68%), with a considerable percentage of females having estrus signs during out-of-season (OS) period (32%). At the mid and late luteal phases of estrus cycles, the NS breeding group had significantly higher serum progesterone level than that reported in the OS group (p = 0.013 and 0.039, respectively). At the estrus and late luteal phases of estrus cycles, the NS breeding group had significantly higher serum β-estradiol level than that reported in the OS group (p = 0.022 and 0.001, respectively). Compared to the OS group, the NS breeding group had significantly higher serum cholesterol at the mid and late luteal phases of estrus cycle (p = 0.001 and 0.016, respectively), and higher serum glucose level in the early luteal phase of the cycle (p = 0.009). In conclusion, the NS breeding goats had superior progesterone (mid-luteal and late luteal phases) and estradiol (estrus and late luteal phases) profiles than that reported in the OS group. This may indicate specific approaches to maintain the breeding efficiency of goats during the out-of-season period.